AVEO Acquisition Brings LG Chem Marketed Oncology Drug, US Commercial Footprint
Milestone In Korean Pharma Development
The acquisition of the US oncology-focused firm will immediately build the commercial presence of the affiliate of the major South Korean conglomerate in oncology through Fotivda, while bringing LG Chem a step closer to its ambitions of becoming a major global pharma operation.
